Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02651428 · ClinicalTrials.gov registry record · Phase 3
Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
A Phase 3 study, sponsored by CorMedix.
- Completed
- Registry status
- Phase 3
- Development phase
- 806
- Enrollment target
NCT02651428: Completed Phase 3 study, sponsored by CorMedix.
NCT02651428 is a Phase 3 study that has completed, run by CorMedix. The registered enrollment target is 806 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02651428, a Phase 3 study, has completed, sponsored by CorMedix.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 806 participants
- Enrollment target
Study Summary
The purpose of this study is determine safety and effectiveness of Neutrolin, a catheter lock solution, for prevention of central venous catheter associated bloodstream infection in hemodialysis patients.
Primary Outcome
CRBSI was defined as the same organism grown from at least one positive blood culture from a peripheral site or bloodline sample, or either the arterial or venous catheter hub. The final assessment of CRBSI was determined by a Clinical Adjudication Committee (CAC) who used both clinical documentation and blood culture results in their assessment.
Interventions
- DRUG Heparin
- DRUG Neutrolin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 806 participants |
| Start Date | 2015-12 |
| Est. Completion | 2018-10 |
| Phase | Phase 3 |
What the finished NCT02651428 record still lists
NCT02651428 is an interventional study that assigns participants to a tested intervention. The registered 806 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Heparin is the first listed.
NCT02651428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02651428 about?
NCT02651428 is a clinical study titled "Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection". The purpose of this study is determine safety and effectiveness of Neutrolin, a catheter lock solution, for prevention of central venous catheter associated bloodstream infection in hemodialysis patients.
What is the current status of trial NCT02651428?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 806 participants. The study started on 2015-12. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02651428?
The interventions under investigation include: Heparin (DRUG), Neutrolin (DRUG).
Who is sponsoring clinical trial NCT02651428?
This trial is sponsored by CorMedix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02651428's enrollment target sits among peer trials
806 411th of 2000 higher than 1,590 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia